Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction von Solomon, Scott D., McMurray, John J.V., Claggett, Brian, de Boer, Rudolf A., DeMets, David, Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe, Shah, Sanjiv J., Desai, Akshay S., Jhund, Pardeep S., Belohlavek, Jan, Chiang, Chern-En, Borleffs, C. Jan Willem, Comin-Colet, Josep, Dobreanu, Dan, Drozdz, Jaroslaw, Fang, James C., Alcocer-Gamba, Marco Antonio, Al Habeeb, Waleed, Han, Yaling, Cabrera Honorio, Jose Walter, Janssens, Stefan P., Katova, Tzvetana, Kitakaze, Masafumi, Merkely, Béla, O’Meara, Eileen, Saraiva, Jose Francisco Kerr, Tereshchenko, Sergey N., Thierer, Jorge, Vaduganathan, Muthiah, Vardeny, Orly, Verma, Subodh, Pham, Vinh Nguyen, Wilderäng, Ulrica, Zaozerska, Natalia, Bachus, Erasmus, Lindholm, Daniel, Petersson, Magnus, Langkilde, Anna Maria

Volltext

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 von Sadoff, Jerald, Gray, Glenda, Vandebosch, An, Cárdenas, Vicky, Shukarev, Georgi, Grinsztejn, Beatriz, Goepfert, Paul A, Truyers, Carla, Fennema, Hein, Spiessens, Bart, Offergeld, Kim, Scheper, Gert, Taylor, Kimberly L, Robb, Merlin L, Treanor, John, Barouch, Dan H, Stoddard, Jeffrey, Ryser, Martin F, Marovich, Mary A, Neuzil, Kathleen M, Corey, Lawrence, Cauwenberghs, Nancy, Tanner, Tamzin, Hardt, Karin, Ruiz-Guiñazú, Javier, Le Gars, Mathieu, Schuitemaker, Hanneke, Van Hoof, Johan, Struyf, Frank, Douoguih, Macaya

Volltext

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes von Bakris, George L, Agarwal, Rajiv, Anker, Stefan D, Pitt, Bertram, Ruilope, Luis M, Rossing, Peter, Kolkhof, Peter, Nowack, Christina, Schloemer, Patrick, Joseph, Amer, Filippatos, Gerasimos

Volltext

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction von McMurray, John J.V, Solomon, Scott D, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Anand, Inder S, Bělohlávek, Jan, Böhm, Michael, Chiang, Chern-En, Chopra, Vijay K, de Boer, Rudolf A, Desai, Akshay S, Diez, Mirta, Drozdz, Jaroslaw, Dukát, Andrej, Ge, Junbo, Howlett, Jonathan G, Katova, Tzvetana, Kitakaze, Masafumi, Ljungman, Charlotta E.A, Merkely, Béla, Nicolau, Jose C, O’Meara, Eileen, Petrie, Mark C, Vinh, Pham N, Schou, Morten, Tereshchenko, Sergey, Verma, Subodh, Held, Claes, DeMets, David L, Docherty, Kieran F, Jhund, Pardeep S, Bengtsson, Olof, Sjöstrand, Mikaela, Langkilde, Anna-Maria

Volltext

Empagliflozin in Heart Failure with a Preserved Ejection Fraction von Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Ferreira, João P, Bocchi, Edimar, Böhm, Michael, Brunner–La Rocca, Hans-Peter, Choi, Dong-Ju, Chopra, Vijay, Chuquiure-Valenzuela, Eduardo, Giannetti, Nadia, Gomez-Mesa, Juan Esteban, Janssens, Stefan, Januzzi, James L, Gonzalez-Juanatey, Jose R, Merkely, Bela, Nicholls, Stephen J, Perrone, Sergio V, Piña, Ileana L, Ponikowski, Piotr, Senni, Michele, Sim, David, Spinar, Jindrich, Squire, Iain, Taddei, Stefano, Tsutsui, Hiroyuki, Verma, Subodh, Vinereanu, Dragos, Zhang, Jian, Carson, Peter, Lam, Carolyn Su Ping, Marx, Nikolaus, Zeller, Cordula, Sattar, Naveed, Jamal, Waheed, Schnaidt, Sven, Schnee, Janet M, Brueckmann, Martina, Pocock, Stuart J, Zannad, Faiez, Packer, Milton

Volltext

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes von Frías, Juan P, Davies, Melanie J, Rosenstock, Julio, Pérez Manghi, Federico C, Fernández Landó, Laura, Bergman, Brandon K, Liu, Bing, Cui, Xuewei, Brown, Katelyn

Volltext

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy von Perkovic, Vlado, Jardine, Meg J, Neal, Bruce, Bompoint, Severine, Heerspink, Hiddo J.L, Charytan, David M, Edwards, Robert, Agarwal, Rajiv, Bakris, George, Bull, Scott, Cannon, Christopher P, Capuano, George, Chu, Pei-Ling, de Zeeuw, Dick, Greene, Tom, Levin, Adeera, Pollock, Carol, Wheeler, David C, Yavin, Yshai, Zhang, Hong, Zinman, Bernard, Meininger, Gary, Brenner, Barry M, Mahaffey, Kenneth W

Volltext

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes von Husain, Mansoor, Birkenfeld, Andreas L, Donsmark, Morten, Dungan, Kathleen, Eliaschewitz, Freddy G, Franco, Denise R, Jeppesen, Ole K, Lingvay, Ildiko, Mosenzon, Ofri, Pedersen, Sue D, Tack, Cees J, Thomsen, Mette, Vilsbøll, Tina, Warren, Mark L, Bain, Stephen C

Volltext

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure von Packer, Milton, Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Pocock, Stuart J, Carson, Peter, Januzzi, James, Verma, Subodh, Tsutsui, Hiroyuki, Brueckmann, Martina, Jamal, Waheed, Kimura, Karen, Schnee, Janet, Zeller, Cordula, Cotton, Daniel, Bocchi, Edimar, Böhm, Michael, Choi, Dong-Ju, Chopra, Vijay, Chuquiure, Eduardo, Giannetti, Nadia, Janssens, Stefan, Zhang, Jian, Gonzalez Juanatey, Jose R, Kaul, Sanjay, Brunner-La Rocca, Hans-Peter, Merkely, Bela, Nicholls, Stephen J, Perrone, Sergio, Pina, Ileana, Ponikowski, Piotr, Sattar, Naveed, Senni, Michele, Seronde, Marie-France, Spinar, Jindrich, Squire, Iain, Taddei, Stefano, Wanner, Christoph, Zannad, Faiez

Volltext

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial von Garvey, W Timothy, Frias, Juan P, Jastreboff, Ania M, le Roux, Carel W, Sattar, Naveed, Aizenberg, Diego, Mao, Huzhang, Zhang, Shuyu, Ahmad, Nadia N, Bunck, Mathijs C, Benabbad, Imane, Zhang, Xiaotian M, Abalos, Franklin H., Manghi, Federico C.P., Zaidman, Cesar J., Vico, Marisa L., Aizenberg, Diego, Costanzo, Pablo R., Serra, Leonardo P., MacKinnon, Ignacio J., Hissa, Miguel N., Vidotti, Maria H., Kerr Saraiva, Jose F., Alves, Breno B., Franco, Denise R., Moratto, Otavio, Murthy, Sreenivasa, Goyal, Ghanshyam, Yamasaki, Yoshimitsu, Sato, Nobuyuki, Inoue, Satoshi, Asakura, Taro, Shestakova, Marina, Khaykina, Elena, Troshina, Ekaterina, Vorokhobina, Natalia, Ametov, Alexander, Tu, Shih-Te, Yang, Chwen-Yi, Lee, I-Te, Huang, Chien-Ning, Ou, Horng-Yih, Freeman, George, Machineni, Sriram, Klein, Klara, Sultan, Senan, Parsa, Alan, Otero-Martinez, Juan, Gonzalez, Alex, Bhargava, Anuj, Brian, Susan, Ince, Carlos, Plantholt, Stephen, Cole, Jeremy, Lacour, Audrey, Vega, Damaris, de Souza, Jose, Rohlf, Jane L., St. John, Roy C., Horowitz, Barry, Audish, Hanid, Galindo, Rodolfo, Umpiperrez, Guillermo, Ard, Jamy, Curtis, Brian, Garvey, William T., Fraser, Neil J., Mandry, Jose, Mohseni, Rizwana, Mayfield, Ronald, Powell, Talessa, Vance, Carl, Ong, Stephen, Lewy-Alterbaum, Ana L., Murray, Alexander, Al-Karadsheh, Amer, Yacoub, Tamer, Roberts, Kevin, Fried, David L., Rosenstock, Julio, Pulla, Bharathi, Bode, Bruce, Frias, Juan, Klaff, Leslie, Brazg, Ronald, Van, Joanna, Tan, Anjanette, Briskin, Toby, Rhee, Margaret, Chaicha-Brom, Tira, Hartley, Paul A., Nunez, Lazaro, Cortes-Maisonet, Gregorio, Soucie, Gary, Hsia, Stanley, Jones, Thomas

Volltext

Dapagliflozin in Patients with Chronic Kidney Disease von Heerspink, Hiddo J.L, Stefánsson, Bergur V, Correa-Rotter, Ricardo, Chertow, Glenn M, Greene, Tom, Hou, Fan-Fan, Mann, Johannes F.E, McMurray, John J.V, Lindberg, Magnus, Rossing, Peter, Sjöström, C. David, Toto, Roberto D, Langkilde, Anna-Maria, Wheeler, David C

Volltext

A detailed map of Higgs boson interactions by the ATLAS experiment ten years after the discovery von Aad, G., Leopold, Alexander, Lundberg, Olof, Lund-Jensen, Bengt, Ohm, Christian, Ripellino, Giulia, Shaheen, Rabia, Shope, David R., Strandberg, Jonas, Zwalinski, L., et al

Volltext

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome von Pfeffer, Marc A, Claggett, Brian, Diaz, Rafael, Dickstein, Kenneth, Gerstein, Hertzel C, Køber, Lars V, Lawson, Francesca C, Ping, Lin, Wei, Xiaodan, Lewis, Eldrin F, Maggioni, Aldo P, McMurray, John J.V, Probstfield, Jeffrey L, Riddle, Matthew C, Solomon, Scott D, Tardif, Jean-Claude

Volltext

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S von Sadoff, Jerald, Gray, Glenda, Vandebosch, An, Cárdenas, Vicky, Shukarev, Georgi, Grinsztejn, Beatriz, Goepfert, Paul A, Truyers, Carla, Van Dromme, Ilse, Spiessens, Bart, Vingerhoets, Johan, Custers, Jerome, Scheper, Gert, Robb, Merlin L, Treanor, John, Ryser, Martin F, Barouch, Dan H, Swann, Edith, Marovich, Mary A, Neuzil, Kathleen M, Corey, Lawrence, Stoddard, Jeffrey, Hardt, Karin, Ruiz-Guiñazú, Javier, Le Gars, Mathieu, Schuitemaker, Hanneke, Van Hoof, Johan, Struyf, Frank, Douoguih, Macaya

Volltext

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial von Heerspink, Hiddo J L, Sjöström, C David, Jongs, Niels, Chertow, Glenn M, Kosiborod, Mikhail, Hou, Fan Fan, McMurray, John J V, Rossing, Peter, Correa-Rotter, Ricardo, Kurlyandskaya, Raisa, Stefansson, Bergur V, Toto, Robert D, Langkilde, Anna Maria, Wheeler, David C

Volltext

Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia von Barak, Yoram, Aizenberg, Dov

Volltext

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes von Zinman, Bernard, Wanner, Christoph, Lachin, John M, Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Mattheus, Michaela, Devins, Theresa, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Inzucchi, Silvio E

Volltext

Mitochondria and nucleus cross‐talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer von Shteinfer‐Kuzmine, Anna, Verma, Ankit, Arif, Tasleem, Aizenberg, Or, Paul, Avijit, Shoshan‐Barmaz, Varda

Volltext

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis von Rossing, Peter, Anker, Stefan D, Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M, Birkenfeld, Andreas L, McGill, Janet B, Rosas, Sylvia E, Joseph, Amer, Gebel, Martin, Roberts, Luke, Scheerer, Markus F, Bakris, George L, Agarwal, Rajiv

Volltext

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis von Zhou, Zien, Jardine, Meg J., Li, Qiang, Neuen, Brendon L., Cannon, Christopher P., de Zeeuw, Dick, Edwards, Robert, Levin, Adeera, Mahaffey, Kenneth W., Perkovic, Vlado, Neal, Bruce, Lindley, Richard I.

Volltext